J&J Antipsychotic Paliperidone ER Moves Into Phase III

The drug, a metabolite of risperidone formulated using Alza's OROS controlled-release technology, may give the company a successor for its Risperdal franchise. Risperidone loses patent protection in 2007.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet